Metraipolis › archive › dc_459aaf110ede
Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 Pathways — Europe PMC PMID:42371779
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42371779
- DOI
- 10.1002/advs.76352
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T14:58:44.862Z
- SHA-256 of the archived text
d7ec837541171b01a4a449d1250125b0500fdeb24a50822c38a5e750ffc56f44- Stable URL of this page
https://metraipolis.com/documento/dc_459aaf110ede
How to cite
Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 Pathways — Europe PMC PMID:42371779 — Europe PMC (en), https://europepmc.org/article/MED/42371779 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_459aaf110ede (Metraipolis archive dc_459aaf110ede, sha256 d7ec837541171b01a4a449d1250125b0500fdeb24a50822c38a5e750ffc56f44)
BibTeX
@misc{dc459aaf110ede,
title = {Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 Pathways — Europe PMC PMID:42371779},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42371779},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_459aaf110ede; sha256 d7ec837541171b01a4a449d1250125b0500fdeb24a50822c38a5e750ffc56f44},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42371779. Agents can read the archived copy with the MCP tool read_document.